Why Are U.S. Coronavirus Cases Falling? And Will the Trend Last?

Why Are U.S. Coronavirus Cases Falling? And W...

Up next

Trump vs. the Pope

This week, an unusual disagreement broke out between the president of the United States and Pope Leo XIV. The New York Times Rome bureau chief, Motoko Rich, explains why President Trump cares so much about what the pope thinks, and why it matters that they are so deeply at odds. ...  Show more

Trump’s Risky Strategy to Blockade Iran’s Blockade

Over a month into a war with Iran that has no clear end, President Trump has enforced a blockade, which went into effect on Monday at the Strait of Hormuz. The New York Times reporters David E. Sanger, Rebecca F. Elliott and Eric Schmitt discuss the strategy behind the blockade, ...  Show more

Recommended Episodes

Why U.S. Vaccinations Started Slow And What We Know About The New Coronavirus Variant
Consider This from NPR

Initially, U.S. officials predicted that as many as 20 million Americans would be fully vaccinated before the end of 2020. And while that many vaccine doses were distributed, only a fraction of them have been administered. The federal government has given states control over dist ...  Show more

The pandemic is officially a year old. We've learnt so much.
What's That Rash?

A year ago today, the World Health Organisation officially declared the coronavirus outbreak a "pandemic". In reality, it'd been clear for some time that the SARS-CoV-2 virus wasn't going to go away anytime soon. Cases outside China had been growing fast and Italy was going into ...  Show more

The huge coronavirus challenge facing America's new President
What's That Rash?

Joe Biden has been sworn into office early this morning and now faces a monstrous battle to get COVID under any semblance of control. Yesterday, according to Johns Hopkins University, the US recorded more than 400,000 coronavirus deaths since the pandemic began. As the weeks pass ...  Show more

Are all viral vector vaccines a problem?
What's That Rash?

American health regulators have paused the use of the Johnson & Johnson coronavirus vaccine, following reports of rare blood clotting in six recipients. Like the AstraZeneca vaccine, Johnson & Johnson is what's known as a viral vector vaccine - where another virus is used like a ...  Show more